These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22336085)

  • 1. Naturally occurring resistance mutations to HIV-1 entry inhibitors in subtypes B, C, and CRF31_BC.
    Araújo LA; Junqueira DM; de Medeiros RM; Matte MC; Almeida SE
    J Clin Virol; 2012 May; 54(1):6-10. PubMed ID: 22336085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High prevalence of primary Enfuvirtide (ENF) resistance-associated mutations in HIV-1-infected patients in Hong Kong.
    Leung PH; Chen JH; Wong KH; Chan KC; Lam HY; Cheng VC; Yuen KY; Yam WC
    J Clin Virol; 2010 Mar; 47(3):273-5. PubMed ID: 20116329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients.
    Carmona R; Pérez-Alvarez L; Muñoz M; Casado G; Delgado E; Sierra M; Thomson M; Vega Y; Vázquez de Parga E; Contreras G; Medrano L; Nájera R
    J Clin Virol; 2005 Mar; 32(3):248-53. PubMed ID: 15722032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients.
    Charpentier C; Larrouy L; Visseaux B; Landman R; Levittas M; Storto A; Damond F; Yazdanpanah Y; Yeni P; Brun-Vézinet F; Descamps D
    J Antimicrob Chemother; 2012 Jun; 67(6):1459-61. PubMed ID: 22382470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enfuvirtide (T-20) resistance-related mutations in HIV type 1 subtypes B, C, and F isolates from Brazilian patients failing HAART.
    Oliveira AC; Martins AN; Pires AF; Arruda MB; Tanuri A; Pereira HS; Brindeiro RM
    AIDS Res Hum Retroviruses; 2009 Feb; 25(2):193-8. PubMed ID: 19239358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis and natural polymorphisms in HIV-1 gp41 isolates from Maputo City, Mozambique.
    Ismael N; Bila D; Mariani D; Vubil A; Mabunda N; Abreu C; Jani I; Tanuri A
    AIDS Res Hum Retroviruses; 2014 Jun; 30(6):603-9. PubMed ID: 24188582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation L33M in the HR1 region of HIV-1 gp41 may play a role in T20 resistance.
    Chong H; Xu S; Zhang C; Nie J; Wang Y
    J Clin Virol; 2009 Jul; 45(3):255-8. PubMed ID: 19487156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the envelope genetic context in the development of enfuvirtide resistance in human immunodeficiency virus type 1-infected patients.
    Labrosse B; Morand-Joubert L; Goubard A; Rochas S; Labernardière JL; Pacanowski J; Meynard JL; Hance AJ; Clavel F; Mammano F
    J Virol; 2006 Sep; 80(17):8807-19. PubMed ID: 16912327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of HIV-1 non-B subtypes and recombinant variants to Enfuvirtide.
    Holguín A; Faudon JL; Labernardière JL; Soriano V
    J Clin Virol; 2007 Feb; 38(2):176-80. PubMed ID: 17196877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes.
    Fofana DB; Charpentier C; Maïga AI; Lambert-Niclot S; Sayon S; Désiré N; Simon A; Yazdanpanah Y; Katlama C; Descamps D; Calvez V; Marcelin AG; Soulié C
    J Antimicrob Chemother; 2015 Jan; 70(1):130-5. PubMed ID: 25270328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms in the HIV-1 gp41 env gene, natural resistance to enfuvirtide (T-20) and pol resistance among pregnant Brazilian women.
    Reis MN; de Alcântara KC; Cardoso LP; Stefani MM
    J Med Virol; 2014 Jan; 86(1):8-17. PubMed ID: 24037943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of primary resistance to HIV entry inhibitors among brazilian patients failing reverse transcriptase/protease inhibitors treatment reveal high prevalence of maraviroc resistance-related mutations.
    Alencar CS; Nishiya AS; Ferreira S; Giret MT; Diaz RS; Sabino EC
    AIDS Res Hum Retroviruses; 2010 Dec; 26(12):1267-71. PubMed ID: 20977300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 gp 41 mutations in proviral DNA among antiretroviral treatment-naive individuals from India.
    Sen S; Tripathy SP; Sahni AK; Gupta RM; Kapila K; Chopra GS; Chimanpure VM; Patil AA; Paranjape RS
    AIDS Res Hum Retroviruses; 2009 May; 25(5):521-3. PubMed ID: 19400735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
    de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
    J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant genotypic interpretation and phenotypic role of protease mutations in HIV-1 subtypes B and G.
    Santos AF; Abecasis AB; Vandamme AM; Camacho RJ; Soares MA
    J Antimicrob Chemother; 2009 Mar; 63(3):593-9. PubMed ID: 19136678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-1 subtypes and antiretroviral drug resistance profiles among drug-naïve Brazilian blood donors.
    Sá-Ferreira JA; Brindeiro PA; Chequer-Fernandez S; Tanuri A; Morgado MG
    Transfusion; 2007 Jan; 47(1):97-102. PubMed ID: 17207236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of genotypic resistance to enfuvirtide in HIV-1 isolates from different group M subtypes.
    Covens K; Kabeya K; Schrooten Y; Dekeersmaeker N; Van Wijngaerden E; Vandamme AM; De Wit S; Van Laethem K
    J Clin Virol; 2009 Apr; 44(4):325-8. PubMed ID: 19237313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic changes in human immunodeficiency virus type 1 envelope glycoproteins on treatment with the fusion inhibitor enfuvirtide and their influence on changes in drug susceptibility in vitro.
    Su C; Melby T; DeMasi R; Ravindran P; Heilek-Snyder G
    J Clin Virol; 2006 Aug; 36(4):249-57. PubMed ID: 16765082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIVfird: A Tool for Detection of Resistance to Fusion Inhibitor Drugs in HIV-1 Sequences.
    Barreto Vasconcelos AL; Monteiro-Cunha JP
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):941-947. PubMed ID: 31280582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary HIV-1 drug resistance in the C-terminal domains of viral reverse transcriptase among drug-naïve patients from Southern Brazil.
    Santos AF; Silveira J; Muniz CP; Tornatore M; Góes LR; Mendoza-Sassi RA; Martinez AM; Tupinambás U; Greco DB; Soares MA
    J Clin Virol; 2011 Dec; 52(4):373-6. PubMed ID: 21975076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.